Multi-omic analysis of 579 patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer identifies subgroups of the disease with distinct biological and clinical features.
- Xi Jin
- Yi-Fan Zhou
- Zhi-Ming Shao